Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Real-time Euronext Paris 06:11:35 05/10/2026 pm IST			5-day change	1st Jan Change
0.7430 ^EUR	+6.14%		+2.19%	-22.29%

25/09	Transgene provides update on its operations
08/09	Transgene Expands ProBioGen Partnership With Additional License	MT

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

d5fcc11f830666b9b1a48d178dd8.W0oLFPEo2su78qX2BDVaaW8L6xwnyuqBpk_IFKDeWyU.MgE5dZlvubGMiPqbRkEgKBxMiVJL_aPVxQquI9etERQQCF5yuGvivPrB6A~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

25/06	Oddo BHF Stays Positive on Transgene
07/04	Transgene stands out following licensing agreement with NEC Bio
27/11	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/25/13	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
18/25/18	Transgene: analysts reiterate their recommendations after results
17/25/17	The day the Fed resumed its rate cuts
06/24/06	Transgene: Invest Securities remains Buy
15/24/15	Transgene: Invest Securities confirms its Buy recommendation
26/24/26	Transgene: Invest Securities confirms its opinion
06/23/06	Transgene: Invest Securities confirms its Buy rating
05/23/05	Transgene: Invest Securities reiterates its recommendation
22/23/22	Transgene: Invest Securities reduces its target
10/23/10	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+57.14%
	WUXI APPTEC CO., LTD.					+11.79%
	ARGENX SE					+27.75%
	LONZA GROUP AG					+21.67%
	REVOLUTION MEDICINES, INC.					+24.6%
	IQVIA HOLDINGS INC.					+11.82%
	BEONE MEDICINES AG					+21.07%
	CELLTRION, INC.					+46.63%
	WUXI BIOLOGICS (CAYMAN) INC.					+6.77%
	BIONTECH SE					+20.91%
	Average					+25.01%
	Weighted average by Cap.					+20.75%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7000EUR

Average target price

1.100EUR

Spread / Average Target

+57.14%

High Price Target

1.100EUR

Spread / Highest target

+57.14%

Low Price Target

1.100EUR

Spread / Lowest Target

+57.14%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
TNG Stock
Consensus Transgene

The best tools reserved for subscribers to boost the performance of your investments!